Human studies of Moderna Inc.’s experimental coronavirus vaccine are set to begin this month, positioning it to be first among a host of shots that companies are developing to fight the contagion.
The Moderna product is moving very rapidly and will enter human trials “within a couple of weeks,” said Richard Hatchett, chief executive officer of the Coalition for Epidemic Preparedness Innovations, a group overseeing development of shots against deadly infections. The estimated start of a trial of Moderna’s vaccine is March 19, according to a U.S. government website.
Moderna declined to comment.
As concerns about the...